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Sammanfattning 
Växter har under alla tider använts för att lindra och förhindra olika sjukdomstillstånd. När 
den moderna läkarvetenskapen gjorde sitt intåg så blev huskurer baserade på örter omoderna 
men idag så ökar intresset och användningen av örtmediciner över hela världen. Örterna 
används inte enbart inom homeopatin utan även i den moderna läkarvetenskapen men här så 
utvinns de olika ämnena från växten. Exempel på detta är Taxus baccata och T. brevifolia från 
vilka taxol och baccatin III utvinns för användning inom cancerbehandling.  
Syftet med det här arbetet var att undersöka om användningsområdet för tre vanliga 
medicinalväxter har ändrats i takt med vetenskapliga framsteg och nya metoder. Varje växt 
fick en kortare morfologisk beskrivning följd av en presentation av den dåtida, nutida och 
framtida användningen av växten. Även några av de andra användningsområdena än medicin 
har blivit presenterade i den här rapporten och även en förteckning över de länder där dessa 
växter finns i kommersiell produktion.  
De tre växter som undersökts är Digitalis för dess användning inom hjärtmedicin, Echinacea 
för dess väldigt vanliga användningsområden för att förebygga och förkorta övre 
luftvägsinfektioner och Hypericum för användning både inom den konventionella 
läkarvetenskapen och inom homeopatin för behandling av psykiska problem. 
De tre medicinalväxter som jag valde att skriva om har mer eller mindre samma 
användningsområde idag som de hade då de började användas. För mer allvarliga infektioner 
och sjukdomstillstånd där dessa växter tidigare ansågs som mirakelbotemedel används de 
nuförtiden mycket sällan eller aldrig. Detta beror troligtvis på att i takt med vetenskapliga 
framsteg och den moderna medicinen så har mer effektiva botemedel upptäckts. I några fall så 
har sjukdomen eller sjukdomstillståndet mer eller mindre utrotats i I-länderna. Exempel på 
detta är barnsängsfeber och syfilisinfektioner av andra eller tredje graden.  
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Summary 
Since the beginning of time, the humankind has used plants to cure all sorts of diseases, both 
physiological and psychological. With the entry of modern medicine the herbal remedies 
became unpopular but today herbal medicine is becoming more and more popular all over the 
world. The herbs are not only used in homeopathy but also in more conventional school 
medicine but here the different constituens are extracted from the plants, e.g. Taxus baccata 
and T. brevifolia from which taxol and baccatin III are extracted and used as cancer treatment. 
The aim of the project was to see if the medical use of three medicinal plants has changed 
with the development of new technology and scientific progress. Each plant was given a short 
morphological presentation and thereafter the medical use before, today and in the future was 
presented. In this report some of the other ways to use the different plants are also mentioned 
as well as some of the countries in the world where the plants can be found in commercial 
cultivation.  
The plants chosen are Digitalis for its use as a heart medicine, Echinacea for the very 
common use in both treating and preventing upper respiratory infections and at last 
Hypericum that is used both in conventional medicine and in homeopathy as a treatment for 
psychological disorders.  
The three medical plants that I chose to write about have more or less the same area of usage 
today as they had from the beginning. For more serious infections and other medical 
conditions that are difficult to treat these plants earlier where considered as miracle cures they 
are no longer or to a very small extent used. This is probably due to the fact that with 
scientific progress and the modern medicine new and more effective cures where found. In 
some cases the answer is that the disease or the medical condition is more or less eradicated in 
the western part of the world e.g. child-bed fever and syphilis infections of second to third 
degree. 
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Material and methods  
When this project started the only thing that was clear to me was that this was going to be 
conducted as a literature project and that the content would be about medicinal plants. I was 
suggested by my supervisor to investigate and find three plants that I was especially interested 
in and could find information about. After some search at the library at Alnarp and at the 
Internet I choose three genera and within these some species. The ones that I found were 
Digitalis spp., Echinacea spp. and Hypericum perforatum.  
To present the plants I made a plan, where I start with giving a morphological description, 
followed by the medical uses before, today and in the future. To end with I will shortly 
mention some of the countries where these plants today can be found in commercial 
cultivation. 
To find the information needed the main sources was the library in Alnarp and the Internet. 
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Introduction 
Since the beginning of time, the humankind has used plants to cure all sorts of diseases, both 
physiological and psychological. Today this is made visible through all de remedies and 
dietary supplements in our western culture and in the Traditional Chinese Medicine (TCM) as 
well as in the Indian medical system of Ayurveda. These are just the more commonly known 
users of herbal remedies but of course herbs are used in every culture all over the world. 
In more conventional school medicine constituents from the herbs are used in treating 
different disorders. Examples of this are the Taxus baccata and T. brevifolia from which taxol 
and baccatin III are extracted and used for cancer treatment. Artemisia annua is used in 
producing artemisinin derivates against malaria parasites that have become resistant to 
ordinary medical treatments. This drug is developed from the TCM (Abrahamsson, 2003). 
Another plant that is well known is Papaver somniferum, from which opium and its 
derivatives morphine and codeine can be obtained, both are used as pain killers. Sadly, many 
of the plants used for treating various disorders have been forgotten and need to be 
rediscovered. Today medical companies and universities investigate the whole plant kingdom 
in order to find new plants to be used as treatments in various ways. Also old remedies where 
the functions of the plants have been forgotten are investigated (Lewis & Lewis, 2006).  
This bachelor project is conducted as a literature project. The aim with the project was to see 
if the medical use of three medicinal plants has changed with the development of new 
technology and scientific progress. Each plant will be given a short morphological 
presentation and thereafter the medical use in the past, present and future will be presented. In 
this report some of the other ways to use the different plants are also mentioned as well as 
some of the countries in the world where the plants can be found in commercial cultivation.  
The plants chosen are Digitalis for its use as a heart medicine, Echinacea for the very 
common use in both treating and preventing upper respiratory infections and finally 
Hypericum that is used both in conventional medicine and in homeopathy as a treatment for 
psychological disorders.  
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Digitalis purpurea, D.lanata  Foxglove, Fingerborsblomma, 
Grekisk fingerborgsblomma 
 
Morphology 
Digitalis belongs to the family Scrophulariaceae and the subfamily Rhinanthoideae. The 
subfamily is characterised by having flowers with ascending corolla aestivation, meaning that 
in the bud the lower lip covers the upper lip (Jacobsen & Jensen, 1999). Both Digitalis 
purpurea and D. lanata are biennial to perennial herbs or shrublets that are native to Europe. 
The first year they form a rosette of basal leaves, which are lanceolate in shape. The second 
year a high, upright and mostly unbranched stem with unilateral inflorescence is formed, that 
is the flowers are formed on one side of the stem. The leaves are upright and are placed in a 
spiral. After fertilisation the flowers form a bi-valvate capsule, meaning that the capsule has 
two valves where the seeds are located (Jacobsen & Jensen, 1999; Stodola & Volák, 2000).  
Digitalis purpurea has a stem that is covered in woolly hairs and the lower leaves are 10-
30cm long, have a winged petiole and are ovate to lanceolate in the shape. The tip of the 
leaves is acute and that means the leaves end with a sharp tip. On the lower side of the leaves 
they are canesent i.e. they are densely covered with short, greyish-white hairs and the total 
height of the plant is 100 to 150cm. Flowers that are large and campanulate (formed like 
bells) appear on a unilateral raceme. That is when flowers are on one side of the stem and start 
to flower with the lowest bud first 
and the top at the end of the 
flowering period. Colour of 
flowers can be violet, redish, 
white or pale yellow with a 
pubescent (somewhat hairy) 
inside. The flowers have purple to 
dark red dots on the inside. 
(figure 1) 
 
Figure 1. Digitalis purpurea (Jansson, 2006). 
 The flowering time for D. purpurea is June to August (Botaniska Trädgården, 1998; Hickey 
& King, 2000; Mossberg & Stenberg, 2003; Stodola & Volák, 2000; Cheers, et al. 2003). 
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For D. lanata the stem is tall, around 90cm in height, erect and with many sessile leaves, the 
leaves have no stalk. Compared to the leaves of D.purpurea the leaves on D.lanata are 
smaller, more narrowly lanceolate, with entire to crenate (wavy) leaf margins and they are 
less hairy.The bell shaped flowers are wolly, located on a terminal raceme and the colour of 
the flower is brownish-white 
where the lower lip is white and 
the “bell” is brownish and the 
woolly flowers have given this 
plant one of its common names, 
namely woolly Digitalis. 
(figure 2) 
 The flowering time for D. lanata 
is July to August. (Botaniska 
Trädgården, 1998; Hickey & 
King, 2000; Stodola & Volák, 
Figure 2. Digitalis lanata (Jansson, 2006)                                         2000; Cheers, et al., 2003). 
Medical use in the past 
Digitalis was unknown as a medicinal plant to the ancient Greek and Romans and it was 
poorly known in the mainland of Europe. In Ireland it was used already during the 5th century 
as a cure against childbed fever. In the herbal book Meddoygon Myddwai, Digitalis is 
mentioned as a treatment for headache, tumours in the genital area and carbuncles etc (Hewe, 
1952).   In Wales during the 14th century Digitalis was used as external cover on severely 
infected wounds. In France and Germany Digitalis was found to be useful as a way to treat 
oedema, a disease that mostly was treated with laxative plants, e.g. bark from Alder 
Buckthorn (Frangula alnus). At this point the impact that foxglove has on the heart was not 
yet known (Heino, 2001). Oedema is a condition that occurs when the heart is not strong 
enough to pump the blood back to the heart at a sufficient pressure. When the pressure in the 
vena cava vessel is to low this allows fluids from the blood to leak out into surrounding 
tissues. It is not only the heart that is working insufficiently but also the kidney and this 
makes the body unable to excrete the excess fluid. The fluids fill up every empty space in the 
body give swollen areas causing great stress on the heart and eventually congestive heart 
failure. The fluids can also fill up the lung cavity and unless the patient sat upright all day and 
all night, he or she would drown. Because of the watery fluids filling up the body this disease 
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was called hydrops or more commonly dropsy (Lewis and Lewis, 2006). The plant was also 
used to treat carbuncles, headache, fever and for wound treating. Research has shown that 
extracts from the leaves have a healing effect on lesions induced by X-rays (Nielsen, 1978). 
In the late 18th century medical science was puzzled why a remedy containing 20 herbs could 
be more efficient to treat oedema and various heart and kidney diseases than the ordinary 
medical treatment. The remedy came from a woman in England that treated people with 
herbal drugs; both the profession and the recipes had gone from mother to daughter for 
several generations. The doctors and the scientists tried to persuade the woman to hand them 
the recipe and reveal the secret. But the woman did not give them the recipes so the English 
and French science academies appointed a commission to investigate why this remedy was so 
powerful. The commission gave the English doctor William Withering the assignment to find 
out what the constituent/constituents of action were. After a long time, about 20 years, he 
found out that it was Digitalis that was responsible for most of the impact the remedy had on 
the diseases. He wrote about this in his dissertation, An account of the Foxglove and its 
Medical Uses, with Practical Remarks on Dropsy, and Other Diseases (Heino, 2001 and 
Hewe, 1952) 
 
Present medical use 
Digitalis is known to be very good for various 
heart diseases where the symptoms can be 
congestive heart failure (CHF) and arrhythmia. 
CHF is when the heart does not function 
sufficiently as a pump and this gives rise to either 
congestion of blood in the lungs or backup 
pressure of blood in the veins leading back to the 
heart. Arrhythmia is when the heart beats 
irregularly and there are different forms of 
arrhythmia. Tachycardia is when the heart beats at 
Figure 3. Nr 1:Left lung 2:Right lung 3:Upper body  
4: Lower body 5: Aorta 6: Superior vena cava 7: Inferior vena cava 
8: Pulmonary artery 9: Pulmonary veins 10: Left atrium 11: region of atrioventricular node 12: Left ventricle 
13: Right ventricle 14: Region of sinoatrial node (normal pacemaker) 15: Right atrium. Figure is redrawn from 
Lewis & Lewis, 2006 
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a very fast but regular rhythm, fibrillation is an irregular, rapid twitching and atrial flutter is 
when only every other atrial beat travels through the ventricles (Lewis & Lewis, 2006). 
Today, much of the active substances from Digitalis are made synthetically but in 
homeopathic medicines as well as to some extent conventional medicine the plant is still used. 
In homeopathy, Digitalis is mostly used in medicals for so called old age heart, meaning a 
condition where the heartbeats are less powerful and regular than before, a condition that is 
often combined with sleeping problems and anxiety (Heino, 2001). 
In commercial growing D. lanata is the more common because of the higher disease and cold 
tolerance. Digitalis lanata also has a higher concentration of heart glycosides corresponding 
to about 4 times more effective than those from D. purpurea (Stodola & Volák 2000).  
The active constituents are extracted from the second year leaves and among these the heart 
glycosides (D. purpurea: purpureaglycosides A, B, digitoxin, gitaloxin and gitoxin and from 
D. lanata: lanatosid A, B and C, acetyldigitoxin and digoxin). The glycosides from Digitalis 
leaves strengthen and regulate the hearth rhythm and also act as strong diuretic (Stodola & 
Volák 2000). By increasing the contractibility of the heart muscle it results in slower but 
much stronger heart beats. This is done by slowing down the violently beating ventricles to a 
normal pace by delaying or blocking the transmission of the electric impulse through the 
atrioventricular node (Lewis & Lewis, 2006). 
The Digitalis glycosides compete with potassium for binding on a enzyme called potassium-
ATPase (Na+/K+ -ATPase) and by blocking potassium from binding to this enzyme the heart 
muscle is exposed to calcium for a longer period than normally. This leads to the heart 
contracting more forcefully (Sanchez, 2000). The effects that Digitalis glycosides have on the 
heart are induced both by the ion pumping function and the more recently discovered signal 
transducing function of Na+/K+ -ATPase. This enzyme participates in protein-protein 
interactions that lead to the activation of multiple growth-related signal transduction 
pathways. Some of these pathways play an important role in the increased contractibility of 
the heart that is induced by Digitalis (Kometiani et al. 2004).  
The increased heart beats enlarge the amount of blood being oxygenated by the lungs, as well 
as the blood in general circulation with sometimes as much as 30%. The glycosides do not 
directly affect the kidneys, but by improving the hearth function more blood is starting to 
circulate in the kidneys. This will make them more effective in changing excessive water into 
urine (Stodola & Volák, 2000 and Lewis & Lewis, 2006).  
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All Digitalis glycosides are most often taken orally and the dosage can be as high as 70% of 
the toxic dose. This makes it very important to adjust the dosage after the individual patients 
needs. Digitoxin (figure 4) is somewhat more completely absorbed in the intestine than 
digoxin (figure 5) but on the other hand digoxin has a more rapid diminution of effect. Today 
constituents from D. lanata are more commonly used as prescribed medicines but for a large 
maintenance of doses where the patient would have been forced to take digoxin more than 
once daily, the longer acting 
digitoxin (with a half life of 5-14 
days depending on dosage and 
the patient (Sanchez, 2000)) is 
still the best alternative,  
The Digitalis glycosides are most 
important in treatment and            Figure 4. Chemical formula of Digitoxin. Redrawn from Sanchez 2000. 
 prevention of cardiac failure but they are also of value in treating certain arrhythmias and 
then particularly atrial tachycardia. The aim is to alter the arrhythmia to normal rhythm or to 
control the ventricular rate. Since digitoxin is slowly absorbed it is better to use digoxin or 
lantanosid C, as they are more rapidly absorbed and therefore more rapid in action, to treat 
these conditions (Lewis & Lewis, 
2006). 
The side and toxicity effects for 
the Digitalis glycosides are 
several and some of them are as 
follows: nausea, vomiting, 
irregular heartbeat, vision  
Figure 5. Chemical formula of digoxin. Redrawn from Sanchez, 2000.   
disorders such as changed colours and blurriness, headache and fatigue (Sanchez, 2000).  
Glycosides from Digitalis are not only used for treating heart conditions but can also be used 
for their effect on cancer cells. In the 1960s in vitro studies showed that malignant cells were 
inhibited by cardiac glycosides. But the short-term animal tests that were conducted indicated 
that toxic levels of the glycosides would have been necessary to achieve an anticancer effect 
in humans and very little research within this area was carried out after this discovery. In 1979 
observations made on cancer cells from women with breast cancer showed that the women 
taking Digitalis had more benign characteristics than the cancer cells from women that were 
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not on Digitalis. At a follow up five years later it was observed that the recurrence was 9.6 
times higher for women not taking Digitalis compared to the ones taking the drugs. None of 
these findings led to much research in this area and the possible benefit of Digitalis glycosides 
needs to be further investigated (López- Lázaro, et al. (2005).  
Future medical use. 
When treating heart failure patients with atrial fibrillation the physicians often use digoxin. 
Digoxin does not offer rate control benefits in patients with sinus rhythm, but a study has 
shown that the patients may benefit from the improvement on the cardiac performance that 
the drug induces. Since digoxin in this investigation had no adverse effect on mortality, is 
readily available and inexpensive it should be used in management of heart failure patients in 
sinus rhythm, that is to keep the heart beat at a normal pace (Lewis and Lewis, 2006).  
Another area where the glycosides from Digitalis can be used is when treating cancer, but this 
requires further research. It is not only the heart glycosides from Digitalis that can be useful, 
other heart glycosides such as oleandrin and ouabain have also been subjects for research. The 
heart glycosides have been shown to induce apoptosis in different malignant cells e.g. 
prostate-, breast-, leukemia-, and cancer in the kidney/urinary tract. It seems like that the 
malignant cells are more sensitive to the effects of Digitalis than normal cells (Haux et al., 
2001).  
Research done by Haux et al. (2001) have shown that the TK-10 renal adenocarcinoma cell 
line that is normally considered as one of the most resistant to cancer chemotherapeutic drugs 
was sensitive to digitoxin. In this study this line of cancer was shown to be hypersensitive to 
digitoxin compared to other cancer lines which supports the findings done by Haux et al 
(2001). In this study apoptosis was found in TK-10 cells at digitoxin concentrations of 3 nM. 
It has been shown that high plasma concentrations (more than 21 nM) of digitoxin lowers the 
risk of cancer in the kidney/urinary tract. All these data suggests that digitoxin has a potential 
in treatment of cancer in kidney/urinary tract (López- Lázaro, et al. 2005). Kometiani et al. 
(2004) investigated the effect of the ion pumping and signal transducing functions of Na+/K+ -
ATPase in human breast cancer cells. They found that digitoxin seemed to be more effective 
than digoxin when inhibiting the growth of the cancer cells. If the concentrations of Digitalis 
drugs are sufficiently high they alter the normal Na+ and K+ gradients and are then lethal to 
nearly all mammalian cells. This together with the findings made by López- Lázaro et al. 
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(2005) indicates that cancer cells are more sensitive to an altered Na+ and K+ concentration 
and therefore can be defeated with the use of Digitalis drugs.  
Commercial growing 
Before 1950 the Balkan countries where the major delivers of glycosides from D. lanata but 
trials in Switzerland have been successful and nowadays they deliver a D.lanata drug that is 
of the same high quality as the one from the Balkans (Hewe, 1952) The major part of the 
commercial growing of Digitalis is today in countries like USA, UK, the Netherlands, 
Switzerland, Germany and the former USSR as well as the Balkan countries. (FAO, 2004) 
 
Figure 6. World map where countries with commercial production of Digitalis are coloured with brown. Map 
from www.theodora.com/maps, 2006 
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Echinacea purpurea, E. pallida, E. angustifolia  Purple or 
Red Coneflower Röd Solhatt och Läkerudbeckia 
 
Morphology 
Echinacea belongs to the family Asteraceae and are herbaceous (non woody), perennial plants 
that originated in Northern America. The leaves are petiolate and are found in a basal rosette 
and the stems arise from the rootstock. Echinacea purpurea has a fibrous root system while E. 
pallida has a single taproot (like a carrot). The stems terminate in a long lasting inflorescence, 
the disk flowers (often golden brown to orange) are attached to a conical, hemispherical or 
occasionally flattened receptacle and the receptacle is the bottom of the inflorescence. 
Surrounding the bottom of the inflorescence is a ring of bracts (involucres) of 3-4 series of 
phyllaries (small green leaf- or scale like structures) and each disk floret is subtended on the 
lower side by a modified bract, that protrudes beyond the five-lobed corolla. The distinct form 
of the capitulum (flower head) is due to the sharply tipped bracts, this form has given the 
genus name derived from the Greek word for hedgehog, echinos. Echinacea purpurea flowers 
from late June to September and sometimes even longer and E. pallida has flowering period 
from May to July depending on where it is grown (McKeown, 1999). The ray florets (purple 
to pink) can be descending as for E. pallida or more erect and shorter as for E. purpurea but 
the plants have similar height of 120cm (Cheers et al., 2003). 
 
Figure 7. To the left is Echinacea  purpurea and to the right is Echinacea pallida. Jansson, 2006 
Echinacea angustifolia has a more compact growth pattern, seldom growing taller than 50cm 
in height. The ray florets are bent abruptly backwards (reflexed) and broad in relation to their 
length, length being shorter or equal to the width of the disk. The short and broad reflexed ray 
florets are used when distinguishing E. angustifolia from E. pallida that has narrow and long 
ray florets (McKeown, 1999). The disk is often large and golden brown to orange and eye-
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catching, this is valid for all the different Echinacea species (Hansson, 2005). All Echinacea 
contain medically useful constituents to various degrees but the most used and studied are the 
ones mentioned above.  
Medical use in the past 
Echinacea came to Europe from North America and was in Europe not known as a medical 
plant until the 18th century. In North America the Indians used Echinacea to treat wounds and 
snake bites and it was the most used medicinal herb in USA in the end of 19th-century. In 
the1830´s a man called Rafinesque reported that the Sioux used Echinacea as a way of 
treating sores induced by syphilis. The first time that red and purple coneflowers occurred in a 
patent medicine was in Nebraska, United States of America in the 1870s, but Echinacea did 
not become popular among the Caucasian population until the eclectic school of medicine 
promoted its use for treatment of a great variety of diseases (Lewis & Lewis, 2006). At this 
point Echinacea was used for treating e.g. syphilis, carbuncles, eczema, tropical infections, 
snake and spider bites and diseases such as herpes, blood poisoning and diphtheria. (Juneby, 
1999 and Lewis & Lewis, 2006). The Indians did not only use the plant for treating snakebites 
and wounds, they also used the root to chew on to ease and treat toothache, sore gums and 
throat. The Crow Indians seemed to be the only ones using Echinacea in the way we do today, 
that is to cure colds and other upper respiratory infections (Lewis & Lewis 2006).  
In Europe until around 1930, Echinacea was used to a great extent as a treatment to various 
infection diseases such as blood poisoning, tuberculosis, childbed fever, and skin diseases. It 
was also used as an externally applied analgesic that in a miraculous way soothing pain from 
a burn injure (Heino, 2001). In 1915 when treating patients with tuberculosis a man called von 
Unruh discovered that Echinacea had an immunostimulating effect and this by increasing the 
phagocytic powers, where foreign particles are removed, of leukocytes (the white blood cells). 
After 1930 the chemistry and efficiency of Echinacea was widely explored and in 1950 an 
injectable product made form the fresh E. purpurea juice (Echinacin) was used to treat oral 
and respiratory infections, skin diseases, gynaecological infections and various cancers among 
other diseases. Later on in the 1970s it was found that Echinacin had a clinical value when 
treating inflammatory skin conditions but this was never proven in a controlled study. 
The use of solutions solemnly containing pure Echinacea juice or other plant components is 
no longer advised because of the adverse effects on diabetics and other conditions. The 
solutions containing pure plant extracts are called parental and can cause, depending on 
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dosage, short term fever, nausea and vomiting and this because of a decline in metabolic 
conditions in diabetics (Lewis & Lewis, 2006).  
Present medical use 
Today, Echinacea is mostly used in the same way as ginseng. That is to prevent illness and 
promote well-being and not as much as a cure (Small & Caitling 1999). Recent research has 
shown that red coneflower relieves and shortens the duration of colds and flu like infections 
by early intervention rather than preventing upper respiratory infections. This is probably due 
to the immunostimulating effect that several constituents in Echinacea possess (Lewis & 
Lewis, 2006 and Percival, 2000). 
Red coneflower has been shown to stimulate plasma cells to produce antibodies, to be 
analgesic, stimulate healing of wounds, have a weak antibiotic effect and stimulate the white 
blood cells to phagocytes, i.e. when the white blood-cells eat bacteria and viruses (Heino, 
2001 and Small & Caitling 1999). Today Echinacea is used in immuno-potentiating therapy 
especially for treatment of cold and upper respiratory infections and other minor infections, e. 
g. in the lower urinary tract, that do not require antibiotics. (Lewis & Lewis 2006).  
Both mechanistic and in vitro studies provide evidence that extracts and compounds from 
Echinacea stimulate the immune system and have anti-inflammatory, bactericidal and wound 
healing properties. The compounds that have been found to be immunostimulating, virostatic 
and antibacterial are the alkamides, glycoproteins, caffeic acid derivatives such as cichoric 
acid and echinacoside and the polysaccarides that can be extracted from Echinacea (Lewis & 
Lewis, 2006).  
 
Figure 8. To the left is the chemical formula of echinacoside and to the right is the chemical formula of cichoric 
acid. Redrawn from Bone ,1997 and Letchamo et al.,1999. 
German studies suggested that the benefit of Echinacea lies in its ability to shorten and reduce 
the symptoms of an illness. If a person has a healthy immune system the effect of taking 
Echinacea might be smaller than if the person has an immune disorder of some kind. 
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Echinacea has the potential to boost the phagocytic immune cell response but it appears that it 
is only fresh pressed juice and isolated polysaccharides that have this ability (Percival, 2000).  
The polysaccharide fraction echinacin B enhances the healing of wounds that are difficult to 
heal by an enhanced formation of granulation tissue (Juneby, 1999). It is believed that the 
wound healing properties and then particularly for burn and photodamage of the skin is due to 
the capacity of its polyphenols (e.g. caffeic acid, echinacoside and cynarine) to protect the 
collagen from damage caused by free radicals. Echinacea is found to enhance the effect of 
penicillin and other antibiotics and can thereby decrease the time of use and dosage that is 
required (Lewis & Lewis 2006, and Juneby, 1999). 
Even though numerous investigations, both in vitro and mechanistic, have found a health 
promoting effect of Echinacea this has yet not been proven in properly conducted medical 
investigations done on a large number of humans. So far the studies done on the health 
promoting effect Echinacea has on humans have often  been conducted in small groups and 
with the use of non commercialized and standardized dosage forms. If the investigation has 
been conducted with a large number of persons the data that have been collected are mainly 
anecdotal and supervision of treatment as well as validation of symptoms has not been 
carefully controlled and this leads to results that are more or less scientifically useless (Lewis 
& Lewis, 2006). Many of these investigations have been performed in Germany where the 
market for herbal medicines is very large. More investigations needs to be performed before 
Echinacea can be said to be effective or not (Percival, 2000). 
Even if the health promoting effect has not yet been proven in investigations done on humans 
there seem to be no hazard in an oral use of Echinacea. Some exceptions exist and that is if 
the person taking the drug has an underlying autoimmune aggression and other over reactive 
immune responses such as in the diseases AIDS, multiple sclerosis and tuberculosis or a 
hypersensitivity to asteraceous allergens. Examples given on these asteraceous allergens that 
can cause cross-reactivity are in North America where ragweed (Ambrosia) allergies are 
common or in Europe where chamomile (Chamomilla) tea drinking is common (Lewis and 
Lewis, 2006). Allergic reactions can be asthma, skin rashes and anaphylaxis. The most severe 
form of anaphylaxis is called anaphylactic shock and that condition mostly leads to death 
within a couple of minutes if untreated (Wikipedia, 2006).  
Echinacea is not only useful to humans in a health promoting way, some of the constituents 
can also be used as pesticides. Echinacein is toxic to Aedes mosquito larvae and houseflies 
and eichinolone, which is a juvenilization compound that disrupts the growth of the large 
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milkweed bug and the yellow mealworm (Lewis & Lewis, 2006) E. purpurea is a very 
popular garden flower and the Swedish cultivar E. purpurea ´Magnus´ has become a world 
famous plant (Hansson & Hansson, 2005). The cultivar `Magnus` has been chosen as plant of 
the year by the Perennial Plant Association. This cultivar was selected by Magnus Nilsson 
from Paarp (Påarp) in Scania (Small & Caitling, 1999). 
 
Future medical use. 
Since the mechanism of action is unknown as well as the bioavailability, relative potency or 
synergistic effects of the active compounds extracted form Echinacea the first thing is to 
investigate and find answers to these questions but also to compare the effectiveness of each 
species. This since there is slight variations in the amount of the active constituents between 
the species. Variations between and among the herb species also exist due to geographical 
location, time of harvest, stage of development and growth conditions (Percival, 2000). So far 
it seems like the Echinacea will be used for a long time as a tool to prevent and combat upper 
respiratory infections. 
 
Commercial cultivation… 
The two most commonly grown Echinacea species are E. purpurea and E. pallida. Echinacea 
is today cultivated in Russia where the first farm commercially growing E. purpurea started in 
1936. Russia together with Germany where among the first countries in the world that started 
with commercial cultivation of Echinacea (Juneby, 1999 and Letchamo et al., 2002). 
Echinacea purpurea has since 1981 been commercially grown on a few hectares on a farm 
Frantsilan yrttitila, that is located in  Hämeenkyrö, Finland (Byholm, 2006) 
Until quite recently the major part of Echinacea used in USA came from wild growing 
populations from the Great Plains, but as this resource became smaller and smaller and the 
risk for extinction became greater commercial cultivation of E. purpurea and E. pallida 
started in the north western part of USA. Other Countries in the world where commercial 
cultivation is found are:  western Canada, Austria, Germany, Ukraine, Yugoslavia, Finland, 
South Africa, Brazil, Australia and New Zeeland (Letchamo et al., 2002). Small to very small 
production of Echinacea can also be found in the Netherlands, Italy, France, Sweden and 
Denmark (EHGA, 2004).  
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New countries in the world production of Echinacea are: Chile, Argentine, and Costa Rica 
and they have established field production of Echinacea since 1998. Experimental fields of 
Echinacea have been established in Egypt, Botswana and Zambia. Echinacea purpurea is the 
major cultivated species but both E. pallida and E. angustifolia can be found in commercial 
production, especially in USA and Canada (Letchamo et al., 2002) 
 
Figure 9. World map with countries growing Echinacea coloured in pink. Map is from 
www.theodora.com/maps, 2006 
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Hypericum perforatum  St. John´s wort Äkta johannesört, 
Mannablod 
 
Morphology 
Hypericum perforatum belongs to the family Clusiaceae and is found in Europe, the 
Mediterranean area, and large areas of temperate North America, Asia and Australia as well 
as in tropical mountain regions. (Lewis & Lewis, 2006) It is a perennial herb, 30-50cm in 
height and with somewhat woody, erect stems that lack hairs and are two angular in shape. 
The plant has an underground stem where groups of aboveground stems are attached (Stodola 
& Volák 2000). The stalk is greyish violet in colour and at top densely branched. The plants 
have leaves that lack petioles (sessile) and are opposite, entire, narrowly ovate and lacking 
stipules. The leaves are around 1-2.5cm and have many transparent glandular dots. The 
flowers are placed in terminate compound cyme and the flower colour is yellow. A compound 
cyme is when the inflorescence is branched and there is more than one flower at the end of 
each branch. They are five-merous and with many stamens that are collected in three groups, 
three styles are present. The sepals are acute and often have a few black glandular dots, the 
petals are twice as long as the lanceolate sepals and with a few black glandular dots along the 
edges. 
 The fruit is a capsule having 
three loculi where each locus 
contains many seeds (Mossberg 
& Stenberg, 2003; Krok & 
Almquist, 2003; Botaniska 
Trädgården, 1998; Hickey & 
King, 2000). Hypericum 
maculatum can easily be 
mistaken for being H. 
perforatum, but these two can be 
differentiated on the looks of the 
stalks and the sepals. 
Figure 10. Hypericum perforatum. Jansson, 2006  
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The stalk of H. perforatum has two wings giving the stalk a two-angular shape and sepals that 
are lanceolate, while the stalk of H. maculatum has four wings making the stalk four-angular 
and the sepals are rounded and oval.  
 
 
 
Figure 11. To the left are drawings of stalk and flower of Hypericum perforatum and to the right, stalk and 
flower of Hypericum maculatum. Redrawn from Stodola & Volák, 2000 and Mossberg & Stenberg, 2003. 
If the sepals are mashed a red juice is extracted because of a flavonoglycoside called 
hypericin (Stodola & Volák 2000). The flowering time for H. perforatum is July to September 
(Mossberg, & Stenberg, 2003).  
 
Medical use in the past 
The usage of Hypericum before the modern chemistry came, can be found in the looks of the 
plant. The red juice that is extracted from the flowers when they are crushed, looks like blood 
and has given the plant many of its common names. One of the names is St. John´s wort that 
comes from the tale that the herb arose where the blood from John the Baptist head dripped 
when his decapitated head was carried to Herodes. This is not the only biblical story behind 
the common names of H. perfortaum and all these names gave the plant a place among the 
necessary tools to use when the church performed exorcism. The tips of the plant are 
especially powerful in keeping away undesired elements and bringing luck. Before the 
Christian names and interpretations of the plant became common the flowers where said to be 
derived from the sun (Nielsen, 1978 and Hobbs, 1998). All mental disorders were said to 
come from the devil and the person was possessed. In Norway a person with melancholy was 
believed to become well again if he/she had scraped their head with the fresh juice from St. 
John´s wort. In Sweden it was said to be a miracle cure where the patient sat up and walked 
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away as soon as he/she had taken this miracle medicine (Nielsen, 1978). During the middle 
ages branches of Hypericum were hanged in window and door openings to expel devils and 
evil spirits. The glands on the leaves were assumed to look like wounds and the plant was 
used by the knights of the Most Venerable Order of the Hospital of Saint John of Jerusalem 
(Order of St. John) when treating the wounds that the Roman Catholic knights had gained 
during the crusades (Stodola & Volák 2000). In year 1525 the Swiss physician Paracelsus 
started to use Hypericum to treat psychiatric disorders and since then it has been traditionally 
used all over Europe. The main targets where neuralgia, anxiety, depression and neurosis and 
later on also for treating psychovegetative disturbance and nervous unrest (Medina et al. 
2006). 
Hypericum has been used since the days of Hippocrates as a cooling and anti-inflammatory 
constituent in remedies (Heino, 2001). Two English herbalists from the 17th century, Gerard 
and Culpeper, wrote that St. John´s wort is very useful in treating and healing inwards- and 
deep wounds and bruises. It is also very effective to treat and open obstructions, dissolve 
swellings, as a treatment for snake bites and dropsy as well as a lot of other diseases and 
conditions. The Indians in America used several indigenous species of Hypericum as 
abortifacient, dermatological aid, antidiarrehal, general strengthener and as a febrifuge. When 
the European settlers introduced the St. John´s wort it was also used for these conditions 
(Hobbs, 1998). The Cherokee Indians gave a root infusion of H. perforatum, H. hypericoides 
and H. gentianoides as a wash to their infants in order to give them strength (Lewis & Lewis, 
2006) and the Indians in North America used the leaves as a sedative (Nielsen, 1978). Other 
conditions the H. perforatum was used for in America by the European settlers and their 
offspring during the 19th century, but also to some extent today, was urinary affections, 
diarrhoea, worms, tumours, menorrhagia, hysteria and other psychological problems and 
disorders (Hobbs, 1998) Carl von Linné mentions in his last disputation 1776 that the flowers 
are good against intestine worms and a decoction on the stems is effective against hoarseness. 
In Materia Medica, von Linné recommends the usage of H. perforatum against bloody 
belching, blood in the urine, palpitations and anxiety. Palpitations are when the heart beats 
and can be normal, slow, fast etc. In the 19th century the St. John´s wort was used against 
melancholy, bed wetting and a weakening of the urine-bladder. Kristian Kneipp spoke well 
about the strengthening effect the herb had on the liver (Heino, 2001)  In 1984 the German 
Commission E (commission for approval of herbal medicine) approved Hypericum for 
medical use against these psychiatric disorders (Medina et al. 2006). 
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 Present medical use 
The most common use of H. perforatum is for treatment of mild to moderate depressions e.g. 
during the menopause. It can also be used as an anti-spasmodic medicine at digestion 
problems and stopping/ obstructing diarrhoea. External use on burn wounds and other injuries 
those are difficult to heal (Juneby, 1999 and Juneby, 1977). The St. John´s wort have been 
proven to be effective to heal smaller nerve damages and it can be used in blood purifying 
treatments because of the strengthening effect it has on the liver. (Heino, 2001). Other 
medical conditions where H. perforatum is used are chronic inflammations in internal organs 
and gynaecological disorders (Stodola & Volák, 2000).  
The use of H. perforatum as an antidepressant is due to the selective inhibition of dopamine, 
serotonin and norepinephrine reuptake in the CNS, central nerval system. The effectiveness of 
H. perforatum is equivalent to that of conventional antidepressants (containing e.g. fluoxetine 
[Prozac], maprotiline, imipramine [Tofranil] and bromazepam) when treating mild to 
moderate depressions. It is also used for treating depressive moods, nervous unrest and 
anxiety (Lewis & Lewis, 2006 and Lawvere & Mahoney, 2005). The main components 
behind the antidepressant effects are believed to be hyperforin and hypericin. At least 
hyperforin shows a broad spectrum of 
inhibitory effects that are affecting the 
reuptake of serotonin, noradrenaline, GABA, 
glutamate and dopamine. This can be 
compared to the fact that many of the other 
antidepressant drugs act more or less selective 
as inhibitors to one or several 
nerurotransmittors, most often serotonin 
(Medina et al. 2006).  
Figure 12. Chemical structure of hypericin. Redrawn  
from Lewis & Lewis, 2006. 
Compared to the conventional antidepressants St. John´s wort has fewer side effects. The 
more serious of these are photosensitization and the fact that H. perforatum can affect and 
change the function of other medicines (Lewis & Lewis, 2006).  Photosensitization is a 
condition where skin rashes and blisters appear, this side effect is most common for persons 
with pale skin colour (Heino, 2001). Also eyes should be protected from intense sunlight 
while taking medications containing H. perforatum and this since it can lead to changes in 
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lens protein leading to formation of cataracts, meaning that the crystalline lens in the eye 
becomes whitish and less or no light can reach the retina and vision is reduced (Lewis & 
Lewis, 2006).  
The photosensitization effect comes from the substance hypericin but this constituent can not 
be removed since it has a clear antidepressant effect. This is probably because hypericin 
inhibits the enzyme monoamine oxidase, this substance has also been shown to be effective in 
treating psychosomatic diseases and problems e.g. bed wetting. But one should be aware of 
the fact that hypericin increases the effect of amphetamine and ephedrine which can give 
unwanted effects (Juneby, 1999).  
The St. John´s wort strengthens the liver and the effect can be so strong that the metabolism 
of many medicines is so fast that they lose their effect or become weaker (Heino, 2001). This 
effect on drugs is because H. perforatum induces a hepatic enzyme through activation of the 
cytochrome P450 system, this probably activates P-glycoprotein. Some of the medicines that 
are affected are anticoagulants, antiviral agents and contraceptives that are taken orally and 
this can possibly have serious consequences (Lewis & Lewis, 2006). Other side effects when 
taking Hypericum can be gastrointestinal upset (nausea and vomiting), increased anxiety or 
depression, headache, fatigue, minor palptations and dry mouth (Lawvere & Mahoney, 2005). 
Oil made of St. John´s wort is pain killing and anti-inflammatory when used externally at 
treatment of joint- and muscular pain. It also increases the ability of blood to flow through the 
skin and makes it smooth and evens out lines (Heino, 2001). The oil is also used for treating 
burn and other kinds of wounds and haemorrhoids (Stodola & Volák 2000).  
Some of the constituents of action in H. perforatum are as follows; the volatile oil has a 
wound healing and anti-inflammatory effect. Hyperforine, imanine and novoimanine act as 
antibiotics, the flavonglycosides are mildly diuretic, anti-spasmodic and strengthen the 
capillary walls. Some sedative effect can probably be found in biflavones and the hyperforine 
but this has not yet been verified by clinical tests on humans or in vitro (Juneby, 1999). 
St. John´s wort can also be used to flavour vodka, which is quite common in the Nordic 
countries. The vodka gets a very nice red colour from the plant and is sometimes called 
“Pirkum snaps” (Nielsen, 1978).  
But St. John´s wort is not only beneficial to the humans, in especially USA and Canada as 
well as in other countries in the world H. perforatum is considered a problematic weed that is 
difficult to get rid of (Gibson, 2000). In the beginning the farmers tried to combat the plants 
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with herbicides, but with little success. In 1946, the leaf-beetles Chrysolina quadrigemina and 
to lesser extent C. hyperici were introduced from Australia. Both leaf-beetles have a vast 
appetite for Hypericum and finally the farmers had something to use when fighting the 
Hypericum (Hobbs, 1998). Hypericum perforatum is also a significant cause of livestock 
poisoning. If the plants exist within the grazing area the animals have the sense to avoid these 
plants. The major problem is when livestock eats shoots that are included in weedy hay and 
then they can not avoid it and become poisoned. When livestock, as well as humans, get 
poisoned with Hypericum they develop severe skin lesions and necrosis because their skin 
becomes hypersensitive to the sunlight. This is nowadays called phototoxicity but in older 
literature as well as newer this is referred to as photosensitization (Gibson, 2000). 
Future medical use.  
A German study conducted in 2002 showed that hyperforin has the ability to reduce or stop 
the growth of tumours by apoptosis. This article is in German so I was not able to read the 
whole article but could only read the abstract. 
Hyperforin act as an antibiotic and has been 
shown to inhibit the growth of various rat and 
human tumour cell lines in vivo. It was 
observed that hyperforin increased the activity 
of caspase-9 and caspase-3 and that the 
apoptosis was blocked by the broad-range 
caspase inhibitor zVAD.fmk. It was observed 
that the permeability transition in the  
Figure 13. Chemical structure of hyperforin. Redrawn 
from Lewis and Lewis, 2006.  
mitochondria could not be prevented by zVAD.fmk. and this indicates that mitochondrial 
permeabilization is a cause rather then a consequence of the caspase activation. It was also 
found that hyperforin is capable of releasing cytochrome c from isolated mitochondria. This 
discovery together with the findings concerning mitochondrial permeabilization suggests that 
hyperforin activated a mitochondria- mediated apoptosis pathway. The combination of an 
anti-tumour activity, low toxicity in vivo and a natural abundance of the compound make 
hyperforin very interesting as a potential new member of the group of anticancer plant 
compounds. This of course requires further investigations both in vivo and in vitro (Schempp 
et al. 2002). 
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In another study done by Schempp et al. (2005) they studied the antiangiogenic activity of 
hyperforin in vivo. The animals used where Wistar rats that had been injected with carcinoma 
cells and then treated with peritumoral injections with hyperforin or a solvent. The result was 
that hyperforin significantly inhibited the growth of the tumours, induced apoptosis and 
reduced tumour vascularization. These data suggest that hyperforin can suppress angiogenesis 
by a direct and non-toxic effect on endothelial cells (Schempp et al. 2005). In another study 
hyperforin was found to strongly inhibit angiogenesis in vitro in bovine aortic endothelial 
cells. Hyperforin was also found to inhibit angiogenesis in the in vivo chorioallantoic 
membrane assay (Martinez-Poveda et al. 2005). Angiogenesis is growth of blood vessels, and 
the tumours secrete various growth factors to induce the angiogenesis. The capillary growth in 
to the tumour will provide it with nutrients and by this allowing it to grow from a small 
cluster of cells to a large tumour. Angiogenesis is also required for the distribution or 
metastasis of the tumour. Endothelial cells are much more stable than cancer cells and have a 
longer lifetime making them ideal targets for therapies. This since they don’t carry any drug 
resistance to the next generation and have a slower mitosis rate than cancer cells (Wikipedia).  
The anticancer effect of Hypericum can also be used in photodynamic therapy (PDT). That is 
when a photosensitizing agent, that is hopefully taken up and retained by the tumour, and 
visible light of a wavelength matching the drug are combined. In this study a polarmethanolic 
fraction (PMF) of H. perforatum was used as a photosensitizer and the target cancer was 
human bladder cancer. The tests where conducted in vitro on two different lines of bladder 
cancer, the result was positive and showed that PMF is a potent and effective photosensitizer 
(Stavropoulos et al. 2006). Hypericum has also been investigated for use in PDT treating early 
oesophageal neoplasia. The oesophageal cancer cells where preincubated with hypericin at 
different doses and for different time and then irradiated with light energy dose. The result 
was that hypericin showed strong phototoxic effects and induced apoptosis in a dose 
dependent way (Hopfner et al. 2003). Other areas where Hypericum can have a future 
potential are in treatment of inflammatory skin disorders such as dermatitis and hyperforin 
may have an inhibitory effect Alzheimer´s disease (Medina et al. 2006).  
But all these new applications of Hypericum need to be tested and investigated both in vitro 
and in vivo. Another area where more research is required is how the different constituents of 
Hypericum work and how these affect the chemical components already present in the human 
body. 
 27
Commercial cultivation… 
H. perforatum was earlier mainly collected from wild populations, and is still collected from 
the wild in Bulgaria to an amount of 120 tonnes in year 2004. Commercial production in field 
can be found in the following countries: Germany, Italy, Austria, Slovakia, UK, the 
Netherlands and France, with Germany as the major producer and then in a descending scale 
when taking the area in consideration (EHGA, 2004 and ProFound & Dürbeck, 2005). Other 
countries in Europe that crop Hypericum are Hungary and Poland but for these countries the 
amount of hectares is unknown, in Poland the reason for this is that it is more than 20 000  
farmers that have commercial production of various medicinal plants (IENICA, 2003 and 
ProFound & Dürbeck, 2005). In recent years the cultivation of Hypericum in Poland has had 
some problems with red ring-root, which have forced them to change the cultivation practise 
(Schmidt, 2005) 
Figure 14. World map where countries with production of Hypericum are coloured with 
yellow. Map from www.theodora.com /maps.  
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Discussion and conclusion 
Digitalis has more or less the same usage area today as it has had from the beginning that is to 
treat heart and kidney conditions. In Ireland it was used already during the 5th century as a 
cure against childbed fever, for headache, tumours in the genital area and carbuncles etc 
(Hewe, 1952). In Wales during the 14th century Digitalis was used as external cover on 
severely infected wounds (Heino, 2001), the usage of Digitalis to treat different kinds of 
wounds is also mentioned by Nielsen (1978). But I can’t find any references concerning a 
modern usage of Digitalis as a treatment for wounds that are difficult to heal and serious 
infections. This can of course be due to the fact that today better and more effective drugs 
used for dealing with these problems exist. On the other hand, with more and more bacteria 
becoming resistant to various antibiotics the above mentioned use of Digitalis should be 
further investigated and perhaps some day this old usage of the plant will be applicable again. 
Taking the whole picture of Digitalis in consideration reveals that this medical plant has been 
used in the same way since it was discovered more than 400 years ago. The only difference is 
that today it is known how and to some extent why it works. With new technologies and 
scientific progress new ways of action for this plant have been found and this has given 
Digitalis new areas of usage. One of these areas is as a cancer treatment but as old records 
mention, the plant was used already in the 5th century as a treatment for tumours in the genital 
area (Hewe, 1952) but they don’t say whether the plant extracts are used externally or taken 
orally. The new research has shown that glycosides from Digitalis are efficient in controlling 
and minimizing different malignant cells in e.g., prostate and breast cancer, leucemia, and 
cancer in the kidney/urinary tract (Haux et al. 2001, López- Lázaro, et al. 2005,).  
Echinacea is today used more or less solely to shorten and prevent colds and other upper 
respiratory infections (Lewis & Lewis 2006 and Small & Caitling 1999). This despite the fact 
that there is a scientific dispute going on concerning whether the plant is effective or if it is a 
placebo effect and whether it can prevent or if it only enhances and stimulate the immune 
system and in that way shortens and diminish symptoms. Recent research indicates that the 
plant extracts probably strengthen the immune system and diminish and shorten e.g. colds and 
that it has no preventative effect (Lewis & Lewis, 2006 and Percival, 2000). Even if this 
newer research pointed towards the fact that the plant only strengthens the immune system 
and has no preventive effect, more and extended research needs to be done to show what 
effect Echinacea really has on the human body. Despite this recent discovery Echinacea has 
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been proven to be useful for a number of different conditions such as other kinds of infections 
and inflammatory skin diseases, e.g. eczema. The reason why Echinacea is very little used in 
this area of medicine can be that the needed research does not exist and of course tradition of 
how the plant should be used plays a big role. This even though the plant was used during the 
19th century as a cure for eczema, but the usage was not widespread (Juneby, 1999 and Lewis 
& Lewis, 2006).  
If a plant is used for a specific condition or a specific area within the medicine it is very 
difficult to break that tradition, even if there are proofs that it has had a wider spectrum of 
areas of usage. With more research on how the different plant parts of Echinacea and the 
diverse constituents in these work and what impact they have on the human body the area of 
use will probably be extended. 
Of the three plants that I chose to work with Hypericum is the one that has the longest time of 
use, that has been recorded and can be found in different writings and books, and it seems like 
that Hypericum has been used for psychological disorders all this time. 
It was the tips of the plant that were said to be especially powerful in keeping away undesired 
elements and bringing luck. This since the yellow flowers reminded about the sun which was 
seen as a very powerful sign and the red juice that can be extracted if the flowers are crushed 
look like blood. All mental disorders were said to come from the devil and the person was 
possessed (Nielsen, 1978 and Hobbs, 1998) so this plant that was said to be derived from John 
the Baptiser became a very powerful tool. The Christian way of interpreting the plant was 
perhaps a way for the priests to handle the more pagan interpretation of the morphology of the 
plant so that this effective plant still could be used to help people but at the same time make 
them think about God and praise him. 
The anticancer effect (Schempp et al. 2002, Schempp et al. 2005 and Hopfner et al. 2003) 
that has been discovered is most likely the area of use that will be given a lot of attention in 
the nearest future. All the areas of use need to be more carefully studied and the different 
mechanisms of action as well as the miscellaneous constituents so that the best healing effect 
can be achieved. 
The three medical plants that I chose to write about have more or less the same area of usage 
today as they had from the beginning. For more serious infections and other medical 
conditions that are difficult to treat where these plants earlier where considered as miracle 
cures they are no longer or to a very small extent used. This is probably due to the fact that 
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with scientific progress and the modern medicine new and more effective cures where found. 
In some cases the answer is that the disease or the medical condition is more or less eradicated 
in the western part of the world e.g. child-bed fever and syphilis infections of second to third 
degree. 
With the entrance of the modern medicine and schooled doctors the usage of herbals also 
became unpopular and was seen as unscientific, except for some cases e.g. Digitalis. As soon 
as the active constituents could be maid in a laboratory the plants were less used and the 
research on how they act decreased and this leads to the fact that many areas of usage are 
unknown and yet to be found or have been forgotten. This is not the only problem. When a 
compound from a plant is synthetically made it might loose some of its properties and the 
result is that the impact on the body can be different compared with the plant derived 
compound. The synthetically made compound might be a chimera of the compound in the 
plant and this can give the altered effect. Some of the constituents might act in a synergistic 
complex and if the compounds are separated from the complex the impact the drug have on 
the body might be altered. Instead of a beneficial effect you might not get an effect at all or an 
opposite effect, meaning that the compound is harmful to the body in some way. But on the 
other hand, if the compounds are extracted from plants and the compound is very popular the 
plant is in danger of becoming extinct unless it is possible to grow it commercially as with 
Digitalis and Echinacea. 
It is not only areas of use that have been forgotten and many medicines today have active 
constituents that are from the beginning derived from plants but with time many of them have 
been forgotten. 
From this project I can conclude that herbal medicines have been used for a very long time 
and with new technologies and scientific progress new areas of usage have been found and are 
still discovered and investigated, but the old applications are still valid and the main area of 
use. So therefore I would say that for the three plants discussed in this project the medical use 
has not changed with the development of new technology and scientific progress. This even if 
scientists are still arguing whether the plants are effective or if it is only a placebo effect, 
whether they have a certain area within medicine where they are effective and what 
constituent or constituents are responsible for the effect? 
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